In a recent study published in the medRxiv preprint* server, in response to the COVID-19-associated total death toll reports from 54 European nations, areas, and territories (“CAT”), researchers at ...
Uptake of seasonal influenza and COVID-19 vaccination among risk groups such as older adults in many European Union/European Economic Area member states between 2023 and 2024 has been suboptimal, ...
Europe is entering an era in which a single week of extreme heat could claim as many lives as the deadliest stretch of the COVID-19 pandemic, turning familiar summer discomfort into a mass-casualty ...
Europe's Committee for Medicinal Products for Human Use (CHMP) recommended granting marketing authorization for two vaccines: Fluad (surface antigen, inactivated, adjuvanted) and Flucelvax (surface ...
The political decisions made during 2020 and 2021 to combat the COVID-19 pandemic profoundly altered daily life. Professionally, societies faced partial unemployment and widespread adoption of remote ...
Novavax NVAX announced that the European Commission had granted full marketing authorization for its protein-based COVID-19 vaccine, Nuvaxovid (NVX-CoV2373), in the European Union (EU). The vaccine is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results